• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌中的血管生成概述。

An Overview of Angiogenesis in Bladder Cancer.

机构信息

Department of Natural Science, Middlesex University, London, UK.

Department of Histopathology, Tanta University, Tanta, Egypt.

出版信息

Curr Oncol Rep. 2023 Jul;25(7):709-728. doi: 10.1007/s11912-023-01421-5. Epub 2023 Apr 13.

DOI:10.1007/s11912-023-01421-5
PMID:37052868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10256644/
Abstract

PURPOSE OF THE REVIEW

Angiogenesis plays a key role in bladder cancer (BC) pathogenesis. In the last two decades, an increasing number of publications depicting a multitude of novel angiogenic molecules and pathways have emerged. The growing complexity necessitates an evaluation of the breadth of current knowledge to highlight key findings and guide future research.

RECENT FINDINGS

Angiogenesis is a dynamic biologic process that is inherently difficult to assess. Clinical assessment of angiogenesis in BCs is advancing with the integration of image analysis systems and dynamic contrast-enhanced and magnetic resonance imaging (DCE-MRI). Tumour-associated macrophages (TAMs) significantly influence the angiogenic process, and further research is needed to assess their potential as therapeutic targets. A rapidly growing list of non-coding RNAs affect angiogenesis in BCs, partly through modulation of vascular endothelial growth factor (VEGF) activity. Vascular mimicry (VM) has been repeatedly associated with increased tumour aggressiveness in BCs. Standardised assays are needed for appropriate identification and quantification of VM channels. This article demonstrates the dynamic and complex nature of the angiogenic process and asserts the need for further studies to deepen our understanding.

摘要

目的综述

血管生成在膀胱癌(BC)发病机制中起关键作用。在过去的二十年中,大量描述多种新的血管生成分子和途径的出版物不断涌现。不断增加的复杂性需要评估当前知识的广度,以突出关键发现并指导未来的研究。

最新发现

血管生成是一个动态的生物学过程,本质上难以评估。BC 中血管生成的临床评估随着图像分析系统以及动态对比增强和磁共振成像(DCE-MRI)的整合而不断发展。肿瘤相关巨噬细胞(TAMs)显著影响血管生成过程,需要进一步研究以评估它们作为治疗靶点的潜力。大量非编码 RNA 影响 BC 中的血管生成,部分通过调节血管内皮生长因子(VEGF)的活性。血管模拟(VM)在 BC 中与肿瘤侵袭性增加反复相关。需要标准化的检测方法来适当识别和定量 VM 通道。本文展示了血管生成过程的动态和复杂性质,并强调需要进一步研究以加深我们的理解。

相似文献

1
An Overview of Angiogenesis in Bladder Cancer.膀胱癌中的血管生成概述。
Curr Oncol Rep. 2023 Jul;25(7):709-728. doi: 10.1007/s11912-023-01421-5. Epub 2023 Apr 13.
2
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer.动态对比增强磁共振成像作为膀胱癌肿瘤血管生成评估的诊断工具。
Can Assoc Radiol J. 2019 Aug;70(3):254-263. doi: 10.1016/j.carj.2018.11.004. Epub 2019 Mar 25.
3
Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer.血管内皮生长因子:膀胱癌中一种重要的血管生成介质。
Eur Urol. 1999 Jan;35(1):2-8. doi: 10.1159/000019811.
4
Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.动态对比增强磁共振成像灌注参数与直肠癌血管生成及生物学侵袭性的相关性:初步结果
J Magn Reson Imaging. 2015 Feb;41(2):474-80. doi: 10.1002/jmri.24541. Epub 2013 Dec 21.
5
The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer.缺氧和p53在膀胱癌血管生成调控中的作用。
J Urol. 2001 Jun;165(6 Pt 1):2075-81. doi: 10.1097/00005392-200106000-00073.
6
Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients.肿瘤相关巨噬细胞与结直肠癌患者的微血管床扩展相关。
J Cell Mol Med. 2016 Jul;20(7):1373-80. doi: 10.1111/jcmm.12826. Epub 2016 Apr 22.
7
Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.膀胱癌中的淋巴管生成与血管生成:血管内皮生长因子-A、-C和-D的预后意义及调控
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):800-6. doi: 10.1158/1078-0432.CCR-05-1284.
8
Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges.血管内皮生长因子(VEGF)信号在肿瘤血管生成中的作用:潜力与挑战。
Curr Vasc Pharmacol. 2017;15(4):339-351. doi: 10.2174/1570161115666170105124038.
9
Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.血红素加氧酶-1 促进膀胱尿路上皮癌的血管生成。
Oncol Rep. 2011 Mar;25(3):653-60. doi: 10.3892/or.2010.1125. Epub 2010 Dec 27.
10
[Angiogenesis in bladder: prognosis indicator and therapeutic target].[膀胱中的血管生成:预后指标与治疗靶点]
Prog Urol. 2001 Jun;11(3):417-27.

引用本文的文献

1
The role of angiogenin in bladder cancer: where are we in 2025?血管生成素在膀胱癌中的作用:到2025年我们处于什么阶段?
Int Urol Nephrol. 2025 Apr 22. doi: 10.1007/s11255-025-04517-y.
2
Review of recent molecular pathology of bladder urothelial carcinoma.膀胱尿路上皮癌近期分子病理学综述。
Discov Oncol. 2025 Mar 29;16(1):424. doi: 10.1007/s12672-025-02128-8.
3
Exosomes containing miR-152-3p targeting FGFR3 mediate SLC7A7-induced angiogenesis in bladder cancer.含有靶向FGFR3的miR-152-3p的外泌体介导SLC7A7诱导的膀胱癌血管生成。
NPJ Precis Oncol. 2025 Mar 12;9(1):71. doi: 10.1038/s41698-025-00859-z.
4
Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis.尿路上皮癌中抗血管生成疗法联合免疫检查点阻断:系统评价与荟萃分析。
Bladder Cancer. 2024 Dec 20;10(4):300-312. doi: 10.1177/23523735241296763. eCollection 2024 Dec.
5
Construction and verification of a prognostic model for bladder cancer based on disulfidptosis-related angiogenesis genes.基于二硫键连接的细胞焦亡相关血管生成基因构建及验证膀胱癌预后模型
PeerJ. 2025 Feb 21;13:e18911. doi: 10.7717/peerj.18911. eCollection 2025.
6
Vascular endothelial cell injury: causes, molecular mechanisms, and treatments.血管内皮细胞损伤:原因、分子机制及治疗方法。
MedComm (2020). 2025 Jan 16;6(2):e70057. doi: 10.1002/mco2.70057. eCollection 2025 Feb.
7
Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway.关于PROS1通过AKT/GSK3β/β-连环蛋白途径抑制膀胱癌进展和血管生成的机制性见解。
Sci Rep. 2025 Feb 8;15(1):4748. doi: 10.1038/s41598-025-89217-4.
8
Diagnostic value of dual-layer spectral detector CT parameters for differentiating high- from low-grade bladder cancer.双层光谱探测器CT参数对鉴别高级别与低级别膀胱癌的诊断价值
Insights Imaging. 2025 Jan 2;16(1):6. doi: 10.1186/s13244-024-01881-8.
9
Molecular mechanism of anticancer effect of heat shock protein 90 inhibitor BIIB021 in human bladder cancer cell line.热休克蛋白 90 抑制剂 BIIB021 抑制人膀胱癌的分子机制。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):5167-5177. doi: 10.1007/s00210-024-02950-x. Epub 2024 Jan 19.
10
Tumor-derived exosomal miR-1247-3p promotes angiogenesis in bladder cancer by targeting FOXO1.肿瘤来源的外泌体 miR-1247-3p 通过靶向 FOXO1 促进膀胱癌血管生成。
Cancer Biol Ther. 2024 Dec 31;25(1):2290033. doi: 10.1080/15384047.2023.2290033. Epub 2023 Dec 10.

本文引用的文献

1
An angiogenesis‑related lncRNA signature for the prognostic prediction of patients with bladder cancer and LINC02321 promotes bladder cancer progression via the VEGFA signaling pathway.一个与血管生成相关的 lncRNA 标志物,用于预测膀胱癌患者的预后,LINC02321 通过 VEGFA 信号通路促进膀胱癌进展。
Mol Med Rep. 2023 Feb;27(2). doi: 10.3892/mmr.2022.12925. Epub 2022 Dec 29.
2
Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features.缺氧诱导因子-2 改变的尿路上皮癌:临床和基因组特征。
Curr Oncol. 2022 Nov 14;29(11):8638-8649. doi: 10.3390/curroncol29110681.
3
The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.TFAP2A通过一种新型长链非编码RNA TPRG1-AS1/DNMT3A/CRTAC1轴在膀胱尿路上皮癌中的致癌作用。
Cell Signal. 2023 Feb;102:110527. doi: 10.1016/j.cellsig.2022.110527. Epub 2022 Nov 21.
4
Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review.尿微小RNA作为膀胱癌诊断工具的系统评价
Biomedicines. 2022 Oct 31;10(11):2766. doi: 10.3390/biomedicines10112766.
5
Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer.肿瘤来源的外泌体非编码 RNA 作为癌症的诊断生物标志物。
Cell Mol Life Sci. 2022 Oct 29;79(11):572. doi: 10.1007/s00018-022-04552-3.
6
LINC00958 Inhibits Autophagy of Bladder Cancer Cells via Sponge Adsorption of miR-625-5p to Promote Tumor Angiogenesis and Oxidative Stress.LINC00958 通过海绵吸附 miR-625-5p 抑制膀胱癌细胞自噬,促进肿瘤血管生成和氧化应激。
Oxid Med Cell Longev. 2022 Oct 10;2022:2435114. doi: 10.1155/2022/2435114. eCollection 2022.
7
Expression of GLUT4 and FAP in urothelial bladder carcinoma: correlation with angiogenesis and clinicopathological characteristics.GLUT4 和 FAP 在尿路上皮膀胱癌中的表达:与血管生成和临床病理特征的相关性。
J Egypt Natl Canc Inst. 2022 Sep 26;34(1):40. doi: 10.1186/s43046-022-00145-0.
8
Farnesoid X Receptor Overexpression Decreases the Migration, Invasion and Angiogenesis of Human Bladder Cancers via AMPK Activation and Cholesterol Biosynthesis Inhibition.法尼醇X受体过表达通过激活AMPK和抑制胆固醇生物合成降低人膀胱癌的迁移、侵袭和血管生成。
Cancers (Basel). 2022 Sep 9;14(18):4398. doi: 10.3390/cancers14184398.
9
Bladder Cancer-Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP-Related Metabolic Reprogramming and SerRS O-GlcNAcylation in Endothelial Cells.膀胱癌衍生的小细胞外囊泡通过诱导内皮细胞 HBP 相关代谢重编程和 SerRS O-GlcNAc 化促进肿瘤血管生成。
Adv Sci (Weinh). 2022 Oct;9(30):e2202993. doi: 10.1002/advs.202202993. Epub 2022 Aug 31.
10
Enhancement of Farnesoid X Receptor Inhibits Migration, Adhesion and Angiogenesis through Proteasome Degradation and VEGF Reduction in Bladder Cancers.法尼醇 X 受体激动剂通过蛋白酶体降解和降低 VEGF 抑制膀胱癌迁移、黏附和血管生成。
Int J Mol Sci. 2022 May 9;23(9):5259. doi: 10.3390/ijms23095259.